{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:27:57Z","timestamp":1648826877310},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T00:00:00Z","timestamp":1395964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00393-013-1243-5","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T17:26:14Z","timestamp":1395854774000},"page":"225-232","source":"Crossref","is-referenced-by-count":1,"title":["Prophylaxe und Behandlung von Infektionen beim \u00e4lteren Rheumapatienten"],"prefix":"10.1007","volume":"73","author":[{"given":"C.","family":"Kneitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Strangfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,28]]},"reference":[{"key":"1243_CR1","first-page":"68","volume":"3","author":"Adrian","year":"2013","unstructured":"Adrian JR, Chirkova T, Kim JH et al (2013) Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis 3:68\u201390","journal-title":"Aging Dis"},{"key":"1243_CR2","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0961203306071919","volume":"15","author":"Bosch","year":"2006","unstructured":"Bosch X, Guilabert A, Pallar\u00e9s L et al (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15:584\u2013589","journal-title":"Lupus"},{"key":"1243_CR3","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"Carmona","year":"2005","unstructured":"Carmona L, Gomez-Reino J, Rodr\u0131guez-Valverde V et al (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766\u20131772","journal-title":"Arthritis Rheum"},{"key":"1243_CR4","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1002\/art.34530","volume":"64","author":"Crowson","year":"2012","unstructured":"Crowson CS, Hoganson DD, Fitz-Gibbon PD, Matteson EL (2012) Development and validation of a risk score for serious infection in patients with rheumatoid arthritis. Arthritis Rheum 64:2847\u20132855","journal-title":"Arthritis Rheum"},{"key":"1243_CR5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/acr.21805","volume":"64","author":"Curtis","year":"2012","unstructured":"Curtis JR, Xie F, Chen L et al (2012) Use of a disease risk score to compare serious infections associated with anti-TNF therapy among high versus lower risk rheumatoid arthritis patients. Arthritis Care Res 64:1480\u20131489","journal-title":"Arthritis Care Res"},{"key":"1243_CR6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1055\/s-0031-1273462","volume":"49","author":"Cornberg","year":"2011","unstructured":"Cornberg M, Protzer U, Petersen J et al (2011) Prophylaxis, diagnosis and therapy of hepatitis B virus infection \u2013 the German guideline. Z Gastroenterol 49:871\u2013930","journal-title":"Z Gastroenterol"},{"key":"1243_CR7","doi-asserted-by":"crossref","unstructured":"Diel R, Hauer B, Loddenkemper R et al (2009) Empfehlungen f\u00fcr das Tuberkulosescreening vor Gabe von TNF-\u03b1-Inhibitoren bei rheumatischen Erkrankungen. Pneumologie 63:329\u2013334 (und Z Rheumatol. 2009;68:411\u2013416)","DOI":"10.1055\/s-0029-1214673"},{"key":"1243_CR8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.2010.144741","volume":"70","author":"Dixon","year":"2011","unstructured":"Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case \u2013 control study. Ann Rheum Dis 70:956\u2013960","journal-title":"Ann Rheum Dis"},{"key":"1243_CR9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"Dixon","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD et al (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69:522\u2013528","journal-title":"Ann Rheum Dis"},{"key":"1243_CR10","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR et al (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46:2287\u20132293","journal-title":"Arthritis Rheum"},{"key":"1243_CR11","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR et al (2002) Predictors of infection in rheumatoid arthritis. Arthritis Rheum 46:2294\u20132300","journal-title":"Arthritis Rheum"},{"key":"1243_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2013.00171","volume":"4","author":"Dorrington","year":"2013","unstructured":"Dorrington MG, Bowdish DME (2013) Immunosenescence and novel vaccination strategies for the elderly. Front Immunol 4:171","journal-title":"Front Immunol"},{"key":"1243_CR13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00296-011-1808-z","volume":"32","author":"Feuchtenberger","year":"2011","unstructured":"Feuchtenberger M, Kleinert S, Schwab S et al (2011) Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 32:1533\u20131539","journal-title":"Rheumatol Int"},{"key":"1243_CR14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK et al (2011) Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology 50:124\u2013131","journal-title":"Rheumatology"},{"key":"1243_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","volume":"2","author":"Gavazzi","year":"2002","unstructured":"Gavazzi G, Krause KH (2002) Aging and infection. Lancet Infect Dis 2:659\u2013666","journal-title":"Lancet Infect Dis"},{"key":"1243_CR16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00393-013-1155-4","volume":"72","author":"Goldacker","year":"2013","unstructured":"Goldacker S, Gause AM, Warnatz K, Kommission Pharmakotherapie der DGRh (2013) Vaccination in adult patients with chronic inflammatory rheumatic diseases. Z Rheumatol 72:690\u2013694","journal-title":"Z Rheumatol"},{"key":"1243_CR17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/art.11137","volume":"48","author":"Gomez-Reino","year":"2003","unstructured":"Gomez-Reino JJ, Carmona L, Valverde VR et al (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:122\u2013127","journal-title":"Arthritis Rheum"},{"key":"1243_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2013.00131","volume":"4","author":"Goronzy","year":"2013","unstructured":"Goronzy JJ, Li G, Yang Z, Weyand CM (2013) The janus head of T cell aging \u2013 autoimmunity and immunodeficiency. Front Immunol 4:131","journal-title":"Front Immunol"},{"key":"1243_CR19","first-page":"1","volume":"57","author":"Harpaz","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF et al (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57:1\u201330 (quiz CE2\u20134)","journal-title":"MMWR Recomm Rep"},{"key":"1243_CR20","doi-asserted-by":"crossref","unstructured":"Hazlewood GS, Naimark D, Gardam M et al (2013) Prophylaxis for latent tuberculosis infection prior to anti-TNF therapy in low-risk elderly patients with rheumatoid arthritis: a decision analysis. Arthritis Care Res (Hoboken). doi:10.1002\/acr.22063","DOI":"10.1002\/acr.22063"},{"key":"1243_CR21","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/annrheumdis-2011-200941","volume":"71","author":"Kleinert","year":"2012","unstructured":"Kleinert S, Tony HP, Krueger K et al (2012) Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-\u03b3 release assays under real-life conditions. Ann Rheum Dis 71:1791\u20131795","journal-title":"Ann Rheum Dis"},{"key":"1243_CR22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00393-013-1257-z","volume":"72","author":"Krause","year":"2013","unstructured":"Krause A, Kr\u00fcger K (2013) Pneumokokkenimpfung bei immunsupprimierten Patienten. Z Rheumatol 72:942\u2013946","journal-title":"Z Rheumatol"},{"key":"1243_CR23","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/annrheumdis-2011-200408","volume":"71","author":"Mariette","year":"2012","unstructured":"Mariette X, Baron G, Tubach F et al (2012) Influence of replacing tuberculin skin test with ex vivo interferon gamma release assays on decision to administer prophylactic anti-tuberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis 71:1783\u20131790","journal-title":"Ann Rheum Dis"},{"key":"1243_CR24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2165\/00002512-199506060-00005","volume":"6","author":"Leibovici","year":"1995","unstructured":"Leibovici L (1995) Bacteraemia in the very old. Features and treatment. Drugs Aging 6:456\u2013464","journal-title":"Drugs Aging"},{"key":"1243_CR25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-857X(05)70016-8","volume":"24","author":"Petri","year":"1998","unstructured":"Petri M (1998) Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 24:423\u2013456","journal-title":"Rheum Dis Clin North Am"},{"key":"1243_CR26","first-page":"68","volume":"3","author":"Reber","year":"2012","unstructured":"Reber AI, Chirkova T, Kim JH et al (2012) Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis 3:68\u201390","journal-title":"Aging Dis"},{"key":"1243_CR27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/acr.21838","volume":"65","author":"Ribeiro","year":"2013","unstructured":"Ribeiro AC, Laurindo IM, Guedes LK et al (2013) Abatacept and reduced immune response to pandemic 2009 influenza A\/H1N1 vaccination in patients with rheumatoid arthritis. Arthritis Care Res 65:476\u2013480","journal-title":"Arthritis Care Res"},{"key":"1243_CR28","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1186\/ar3923","volume":"14","author":"Roseman","year":"2012","unstructured":"Roseman C, Truedsson L, Kapetanovic MC (2012) The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis. Arthritis Res Ther 14:R170","journal-title":"Arthritis Res Ther"},{"key":"1243_CR29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0028-1110008","volume":"48","author":"Sarrazin","year":"2010","unstructured":"Sarrazin C, Berg T, Ross RS et al (2010) Update der S3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis C-Virus-Infektion, AWMF-Register-Nr.:021\/012. Z Gastroenterol 48:289\u2013351","journal-title":"Z Gastroenterol"},{"key":"1243_CR30","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/art.23112","volume":"57","author":"Smitten","year":"2007","unstructured":"Smitten AL, Choi HK, Hochberg MC et al (2007) The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum 57:1431\u20131438","journal-title":"Arthritis Rheum"},{"key":"1243_CR31","unstructured":"St\u00e4ndige Impfkommission(STIKO) am Robert-Koch-Institut (2005) Hinweise zu Impfungen f\u00fcr Patienten mit Immundefizienz\/Stand: November 2005. Epidemiologisches Bulletin 39\/2005. http:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2005\/Sonderausgaben\/Sonderdruck_STlKO-Hinweise_Nov-2005.pdf;jsessionid=DC2B1B546D4D01640A4DFEB5FC4783D7.2_cid372?__blob=publicationFile. Zugegriffen 10.03.2014"},{"key":"1243_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.1780170102","volume":"17","author":"Staples","year":"1974","unstructured":"Staples PJ, Gerding DN, Decker JL, Gordon RS Jr (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17:1\u201310","journal-title":"Arthritis Rheum"},{"key":"1243_CR33","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/ard.2011.151043","volume":"70","author":"Strangfeld","year":"2011","unstructured":"Strangfeld A, Eveslage M, Schneider M et al (2011) Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis 70:1914\u20131920","journal-title":"Ann Rheum Dis"},{"key":"1243_CR34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","volume":"301","author":"Strangfeld","year":"2009","unstructured":"Strangfeld A, Listing J, Herzer P et al (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti \u2013 TNF- agents. JAMA 301:737\u2013744","journal-title":"JAMA"},{"key":"1243_CR35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","volume":"4","author":"Thomas","year":"2004","unstructured":"Thomas S, Hall A (2004) What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4:26\u201333","journal-title":"Lancet Infect Dis"},{"key":"1243_CR36","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P et al (2009) Risk of tuberculosis is higher with anti \u2013 tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy the three-year prospective. Arthritis Rheum 60:1884\u20131894","journal-title":"Arthritis Rheum"},{"key":"1243_CR37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00393-013-1154-5","volume":"72","author":"Warnatz","year":"2013","unstructured":"Warnatz K, Goldacker S, Gause AM, die Kommission Pharmakotherapie der DGRh (2013) Impfempfehlungen der Kommission f\u00fcr Pharmakotherapie der DGRh. Z Rheumatol 72:687\u2013689","journal-title":"Z Rheumatol"},{"key":"1243_CR38","unstructured":"Warnatz K, Goldacker S, die Kommission Pharmakotherapie der DGRh (2013) Z Rheumatol 9:909"},{"key":"1243_CR39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.immuni.2006.05.001","volume":"24","author":"Weng","year":"2006","unstructured":"Weng NP (2006) Aging of the immune system: how much can the adaptive immune system adapt? Immunity 24:495\u2013499","journal-title":"Immunity"},{"key":"1243_CR40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.21812","volume":"65","author":"Widdifield","year":"2013","unstructured":"Widdifield J, Bernatsky S, Paterson JM et al (2013) Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res 65:353\u2013361","journal-title":"Arthritis Care Res"},{"key":"1243_CR41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2012-201979","volume":"71","author":"Winthrop","year":"2012","unstructured":"Winthrop KL, Weinblatt ME, Daley CL (2012) You can\u2019t always get what you want, but if you try sometimes (with two tests \u2013 TST and IGRA \u2013 for tuberculosis) you get what you need. Ann Rheum Dis 71:1757\u20131760","journal-title":"Ann Rheum Dis"},{"key":"1243_CR42","doi-asserted-by":"crossref","unstructured":"Zink A, Manger B, Kaufmann J et al (2013) Evaluation of the RABBIT risk score for serious infections. Ann Rheum Dis (Elektronisch publiziert vor Drucklegung)","DOI":"10.1136\/annrheumdis-2013-203341"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1243-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-013-1243-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-013-1243-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T23:24:05Z","timestamp":1565306645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-013-1243-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,28]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1243"],"URL":"https:\/\/doi.org\/10.1007\/s00393-013-1243-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,28]]}}}